Bio-Techne reports Q3 fiscal 2023 results and declares cash dividend; specific figures not available

BIO-TECHNE Corp

2023-Q3 EPS reported $1.30 revenue$835,382,000

Press release for quarter ended March 31, 2023 issued May 3, 2023.
Dividend announcement made same day with no per-share amount disclosed in filing.
No financial figures, guidance, or YoY comparisons provided in the 8-K body.

item 2.02 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

BIO-TECHNE Corp reported financial results for the quarter ended March 31, 2023.

Period: the quarter ended March 31, 2023
Result: reported results

Exact text from the filing

A copy of the press release issued by Bio-Techne Corporation on May 3, 2023, describing the results of operations for the quarter ended March 31, 2023

View on SEC.gov

Browse all earnings releases →

BIO-TECHNE Corp filing history →

Source: SEC EDGAR

accession 0001558370-23-007739

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.